Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics (NASDAQ:CALT) | Old North State Wealth News
Connect with us

Investing

Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics (NASDAQ:CALT)

Published

on

Delmaine Donson

Asahi Kasei (OTCPK:AHKSF) announced an offer to acquire Calliditas Therapeutics AB (publ) (NASDAQ:CALT) for approximately $1.1 billion, which represents an 83% premium to the closing price on the Stockholm exchange and a 74% premium to the closinginitiation article

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.